Effect of Ginsenoside Rh2 Combined with Cisplatin on Apoptosis of Human Ovarian Cancer SKOV-3 Cells

Ying Jin

2012-01-01

Abstract:Objective:To explore the effect of ginsenoside Rh2 combined with cisplatin on human ovarian cancer SKOV-3 cells.Methods:MTT colorimetric method was used to detect the effect of ginsenoside Rh2 combined with cisplatin on proliferation of SKOV-3 cell strains,flow cytometry was used to analyze cell cycle and apoptosis,the average apoptosis rate was calculated,Western blot technique was used to observe the expression of HER-2 protein in SKOV-3 cells.Results:Human ovarian cancer SKOV-3 cell strains were treated with ginsenoside Rh2 combined with cisplatin,single application of cisplatin(350 μmol/L) and IC 50(600 μmol/L),then decreased to 250 μmol/L and 300 μmol/L.Flow cytometry showed that the apoptosis rate of SKOV-3 cells in ginsenoside Rh2 combined with cisplatin group was 32.2%,SKOV-3 cells were inhibited at G1 phase;the apoptosis rate of SKOV-3 cells in cisplatin group was 12.5%,which were both significantly higher than that in single cisplatin group(P0.05),SKOV-3 cells were inhibited at G1 phase.The results of Western blotting showed that the expression level of HER-2 protein in ginsenoside Rh2 combined with cisplatin group was significantly lower than those in control group,cisplatin group,and ginsenoside Rh2 group(P0.05).Conclusion:Ginsenoside Rh2 combined with cisplatin can promote apoptosis of human ovarian cancer SKOV-3 cell strains and improve the sensitivity of human ovarian cancer SKOV-3 cell strains to cisplatin.